Mitera Biosciences Inc. — Form D/A
Mitera Biosciences Inc. of Bellevue, WA, a company, filed a Form D amendment with the SEC on 2025-12-22. The offering totals $2.0M, of which $1.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-12-22
- Form: D/A
- Accession: 0002022224-25-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $1.7M
- Remaining: $255K
- Investors: 6
- Date of first sale: 2024-04-24
- Revenue range: Decline to Disclose
- SEC file number: 021-512804
Issuer
- Name: Mitera Biosciences Inc.
- CIK: 0002022224
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 3120 139th Avenue Southeast Suite 500, Bellevue, WA, 98005
- Phone: 425-818-5036
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Kevin Chow | Director | Bellevue, WA |
| Kevin Chow | Executive Officer | Bellevue, WA |
| Kevin Chow | Promoter | Bellevue, WA |
| Kevin Chow | Related Person | Bellevue, WA |
Other filings by this issuer (2)
More